TITLE

Intravenous iron failed to improve erythropoietic response in patients with chemotherapy-induced anemia

PUB. DATE
December 2010
SOURCE
Hem/Onc Today;12/25/2010, Vol. 11 Issue 24, p40
SOURCE TYPE
Newspaper
DOC. TYPE
Article
ABSTRACT
The article reports on a study which revealed the failure of the addition of intravenous ferric gluconate to improve the erythtropoietic response rate in patients who have chemotherapy-induced anemia.
ACCESSION #
56533954

 

Related Articles

  • Iron status in patients receiving erythropoietin for dialysis-associated anemia. Van Wyck, David B.; Stivelman, John C.; Ruiz, Joaquin; Kirlin, Linda F.; Katz, Murray A.; Ogden, David A. // Kidney International;Feb1989, Vol. 35 Issue 2, p712 

    Adequate body iron stores are crucial to assuring rapid and complete response to recombinant human erythropoietin (rHuEPO). In the present study, markers of iron storage were examined in 27 patients with normochromic, normocytic anemia undergoing acute rHuEPO (150 to 300 U/kg t.i.w.) treatment...

  • Results of an Anemia Management Program To Reduce High Epoetin Doses by Targeted Use Of IV Ferric Gluconate. Coyne, Daniel W.; Sims, Andrea; Bingel, Brenda // Nephrology Nursing Journal;Nov/Dec2008, Vol. 35 Issue 6, p583 

    Intravenous (IV) iron and erythropoiesis-stimulating agents (ESAs) are important therapies in the management of anemia in patients on hemodialysis. However, there is a consensus that ESAs need to be used judiciously - a result of mounting evidence reporting increased risks when targeting higher...

  • Late effects and quality of life.  // Bone Marrow Transplantation;Mar2005 Supplement 2, Vol. 35, p183 

    The article reports that persistent anaemia after allogeneic stem cell transplantation is associated with inadequate erythropoietin (Epo) secretion and easily reverts with erythopoiesis-stimulating proteins. One third of allo-SCT patients needs frequent red-blood-cell transfusion beyond the...

  • Anemia and chronic kidney disease: What's the connection? Taliercio, Jonathan J. // Journal of Family Practice;Jan2010, Vol. 59 Issue 1, p14 

    The article presents a case study of a 65-year-old woman with stage three chronic kidney disease (CKD) and anemia. Anemia of CKD, which has an insidious onset, develops as the failing kidneys produce less erythropoietin (EPO). The diagnosis of CKD anemia include complete blood count, iron...

  • Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy. Kashiwagi, M.; Breymann, C.; Huch, R.; Huch, A. // Archives of Gynecology & Obstetrics;Nov2002, Vol. 267 Issue 1, p54 

    Management of renal anemia in pregnancy remains a major issue. We report the use of human recombinant erythropoietin (rhEPO) combined with parenteral iron sucrose in a pregnancy with chronic glomerulonephritis, progressive anemia and initially normal blood pressure. Therapy from 32 weeks...

  • Is supplementary iron useful when preterm infants are treated with erythropoietin? Ridley, F. C.; Harris, J.; Gottstein, R.; Emmerson, A. J. B. // Archives of Disease in Childhood;Dec2006, Vol. 91 Issue 12, p1036 

    The article focuses on a study that examines the usefulness of supplementary iron when preterm infants are treated with erythropoietin to reduce the requirement for blood transfusion. A preterm infant on the neonatal intensive care unit has developed anemia, which requires a blood transfusion....

  • Adding IV iron to darbepoetin reduced need for transfusions. Shafer, Emily; Jacob, Harry S. // Hem/Onc Today;5/10/2008, Vol. 9 Issue 8, p54 

    The article reports that according to data from two studies published in the "Journal of Clinical Oncology," supplementing darbepoetin alfa, an erythropoiesis-stimulating agent (ESA), with intravenous (IV) iron improved hematopoietic response rate and reduced treatment failure in patients with...

  • Evaluation of The Erythropoietin Responsiveness to Anemia in Type I Diabetic Children. El Hefnawy, H.; Haider, N.; Emara, I.; Ghanem, A. // Nature & Science;Jun2013, Vol. 11 Issue 6, p146 

    Backgrounds and aim of the work: Circulating erythropoietin (EPO) levels increase during hypoglycemia and may represent protective hormonal counter-regulatory responses. The aim of this research was to evaluate the EPO responsiveness to anemia in type 1 diabetic children. Subjects & methods:...

  • Correction of anaemia on dialysis: did we forget physiology? Hertig, Alexandre; Ferrer-Marin, Francisca // Nephrology Dialysis Transplantation;Apr2011, Vol. 26 Issue 4, p1120 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics